Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.